摘要
慢性硬膜下血肿作为一种常见的神经外科疾病,尤其在老年人群中高发。常因基础病症或其他因素需要接受抗栓药物治疗,包括抗血小板和抗凝剂。抗栓药物在慢性硬膜下血肿的发病机制、手术治疗效果以及复发风险和围手术期管理中具有重要影响。近年来,关于抗栓药物在慢性硬膜下血肿患者中的应用研究逐渐增多,但仍存在不少亟待解决的挑战,例如如何有效权衡抗栓药物带来的风险与其治疗益处。本文基于最新研究,综述抗栓药物对患者手术并发症、复发率及预后的影响,旨在为临床合理用药与管理提供参考。
Chronic subdural hematoma is a common neurosurgical condition,particularly prevalent among the elderly population.Patients often require antithrombotic therapy,including antiplatelet agents and anticoagulants,due to underlying diseases or other factors.Antithrombotic drugs significantly influence the pathogenesis of chronic subdural hematoma,the effectiveness of surgical treatment,as well as the risk of recurrence and perioperative management.In recent years,there has been a growing body of research on the application of antithrombotic drugs in patients with chronic subdural hematoma;however,several challenges remain to be addressed,such as how to effectively weigh the risks posed by antithrombotic drugs against their therapeutic benefits.This article is based on the latest research and reviews the effects of antithrombotic drugs on surgical complications,recurrence rates,and prognosis in patients,aiming to provide reference for rational drug use and management in clinical practice.
作者
何文武
苟连平
He Wen-wu;Gou Lian-ping(Department of General Practice,The Affiliated Hospital Of North Sichuan Medical College,Nanchong 637000,Sichuan,China)
关键词
慢性硬膜下血肿
抗栓药物
抗血小板
抗凝药
Chronic subdural hematoma
Antithrombotic drugs
Antiplatelet agents
Anticoagulants
